| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$99 |
Successful A$15 Million Placement To Accelerate Growth
|
2 Jun 2025 9:22AM |
$0.480 |
$0.455 |
fallen by
5.21%
|
|
GHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Golden Horse Minerals Limited (GHM) completed a A$15 million placement.
- Placement was strongly supported by institutional and sophisticated investors.
- Funds will be used for exploration and development of flagship projects.
- The capital enables accelerated drilling and resource expansion.
- Proceeds will also provide flexibility for future acquisitions.
- Placement reflects strong investor confidence in GHM’s strategic direction.
- Funds will be used to fast-track development and deliver shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viva Energy Group Limited (VEA) ORDINARY FULLY PAID |
Energy |
$4,041 |
Initial Director's Interest Notice - John Joyce
|
2 Jun 2025 9:22AM |
$1.870 |
$2.460 |
risen by
31.55%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Weekly NTA Update
|
2 Jun 2025 9:22AM |
$1.610 |
$1.950 |
risen by
21.12%
|
|
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$73 |
Final Director's Interest Notice - Anne Ward
|
2 Jun 2025 9:21AM |
$0.145 |
$0.250 |
risen by
72.41%
|
|
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$1,506 |
Final Director's Interest Notice - Samantha Lewis
|
2 Jun 2025 9:21AM |
$1.615 |
$0.950 |
fallen by
41.18%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
2 Jun 2025 9:20AM |
$1.610 |
$1.950 |
risen by
21.12%
|
|
| 360 Capital Group (TGP) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - TGP
|
2 Jun 2025 9:20AM |
$0.655 |
$0.300 |
fallen by
54.20%
|
|
| EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$27 |
EVR Agrees to Sell Yanamina Gold Project in Peru for US$6m
|
2 Jun 2025 9:19AM |
$0.005 |
$0.009 |
risen by
80%
|
|
EVR - Price-sensitive ASX Announcement
Full Release
Key Points
- EV Resources Limited (EVR) has agreed to sell its Yanamina Gold Project in Peru to Kiwanda S.A.C. for US$6 million.
- The sale aligns with EVR's strategy to focus on its core lithium exploration and development assets.
- The agreement includes a 60-day due diligence period and staged payment structure.
- An initial non-refundable payment is to be made by Kiwanda S.A.C. upon execution of the agreement.
- Completion of the sale is subject to satisfaction of certain conditions precedent.
- Funds raised from the transaction will provide additional working capital for EVR.
- The sale allows EVR to streamline its portfolio and focus resources on its principal lithium operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$16 |
Positive Human PK Study Results for NTI164
|
2 Jun 2025 9:19AM |
$0.021 |
$0.012 |
fallen by
42.86%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurotech International Limited completed first-in-human PK study for NTI164.
- Study conducted in healthy adult volunteers.
- NTI164 was found to be safe and well-tolerated.
- No serious adverse events were reported.
- PK results demonstrate predictable and dose-proportional plasma concentrations.
- Results support continued development of NTI164 for neurological and neuropsychiatric indications.
- Data provides a foundation for future clinical studies in patient populations.
- The announcement strengthens NTI164’s clinical development profile and commercial potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$73 |
Final Director's Interest Notice - Ben Heap
|
2 Jun 2025 9:19AM |
$0.145 |
$0.250 |
risen by
72.41%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,557 |
Update - Notification of buy-back - KAR
|
2 Jun 2025 9:18AM |
$1.665 |
$2.190 |
risen by
31.53%
|
|
| BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$26 |
BSA Leadership Transition and Business Update
|
2 Jun 2025 9:18AM |
$0.065 |
$0.340 |
risen by
423.08%
|
|
BSA - Price-sensitive ASX Announcement
Full Release
Key Points
- Simon Moore, Chair of BSA Limited, will become Executive Chair effective 31 December 2023.
- Current CEO Mark Lowe will depart from BSA Limited at the end of December 2023.
- BSA is conducting a search for a new CEO.
- The company will focus on core technical services, especially in telecommunications and energy infrastructure.
- BSA will exit non-core operations and streamline its business.
- A review of the group’s cost base and structure is underway to align with market conditions.
- Operational improvements have been implemented to address recent trading performance.
- The business update acknowledges challenging market conditions.
- Further updates on the transformation and leadership transition will be provided in due course.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$231 |
Update on US legal proceeding with TherapeuticsMD Inc
|
2 Jun 2025 9:18AM |
$4.950 |
$2.840 |
fallen by
42.63%
|
|
| GCM Corporation Limited (GCM) ORDINARY FULLY PAID |
Materials |
$38 |
Proposed issue of securities - GCM
|
2 Jun 2025 9:18AM |
$0.015 |
$0.013 |
fallen by
13.33%
|
|
| GCM Corporation Limited (GCM) ORDINARY FULLY PAID |
Materials |
$38 |
Proposed issue of securities - GCM
|
2 Jun 2025 9:17AM |
$0.015 |
$0.013 |
fallen by
13.33%
|
|
| GCM Corporation Limited (GCM) ORDINARY FULLY PAID |
Materials |
$38 |
$7M Institutional Placement to Advance VHD to First Revenue
|
2 Jun 2025 9:17AM |
$0.015 |
$0.013 |
fallen by
13.33%
|
|
GCM - Price-sensitive ASX Announcement
Full Release
Key Points
- GCM raised $7 million through an institutional placement to fast-track the Vittangi High-Grade Graphite Deposit (VHD).
- The fundraising was well supported by new and existing institutional investors.
- Funds will be used for resource expansion drilling, feasibility studies, environmental work, offtake agreements, and early stage project activities.
- The VHD project is central to GCM’s strategy to supply high-purity graphite to lithium-ion battery and critical industries.
- GCM aims to align with global trends in decarbonization and electrification.
- Leadership emphasized the placement’s importance for advancing VHD towards first revenue and establishing GCM as a key player in critical minerals.
- The placement strengthens GCM’s financial position for project development and resource expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QuickFee Limited (QFE) ORDINARY FULLY PAID |
Financials |
$29 |
Trading Halt
|
2 Jun 2025 9:17AM |
$0.051 |
$0.076 |
risen by
49.02%
|
|
QFE - Price-sensitive ASX Announcement
Full Release
Key Points
- QuickFee Limited requested a trading halt on its securities on 22 November 2022.
- The trading halt is pending an announcement about a capital raising.
- The halt will be in place until Thursday, 24 November 2022 or an earlier announcement.
- The trading halt aims to ensure disclosure of sensitive information and an orderly market.
- Further details regarding the capital raising will be provided in the upcoming announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$73 |
Update - Notification of buy-back - PCG
|
2 Jun 2025 9:15AM |
$0.790 |
$0.740 |
fallen by
6.33%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,374 |
Update - Notification of buy-back - GNC
|
2 Jun 2025 9:15AM |
$7.680 |
$6.180 |
fallen by
19.53%
|
|
| Estrella Resources Limited (ESR) ORDINARY FULLY PAID |
Materials |
$71 |
Trading Halt
|
2 Jun 2025 9:15AM |
$0.044 |
$0.032 |
fallen by
27.27%
|
|
ESR - Price-sensitive ASX Announcement
Full Release
Key Points
- Estrella Resources Limited requests a trading halt effective 13 June 2023.
- The trading halt is pending an announcement related to a proposed capital raising.
- The halt will end when the announcement is made or at the start of trading on 15 June 2023, whichever is earlier.
- The trading halt is intended to manage disclosure obligations and ensure an informed market.
- The ASX has been requested to grant the trading halt in accordance with Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$67 |
RAD Reports Positive Preclinical Lu177-B7H3-mAb Data
|
2 Jun 2025 9:14AM |
$0.024 |
$0.019 |
fallen by
20.83%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics Limited announced positive preclinical data for its Lu177-B7H3-mAb radiotherapeutic program.
- Preclinical studies demonstrated significant anti-tumor activity of the Lu177-B7H3-mAb in relevant models.
- The therapy exhibited a favorable safety profile in tested preclinical settings.
- B7-H3 is an important target for tumors with high unmet medical needs.
- Preclinical evidence supports progression toward clinical development.
- The announcement reinforces RAD's strategic focus on expanding its targeted radiopharmaceutical pipeline.
- Results position the company for discussions with regulatory authorities and future clinical trials.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Opthea Limited (OPT) ORDINARY FULLY PAID |
Health Care |
$821 |
Final Director's Interest Notice Quinton Oswald
|
2 Jun 2025 9:14AM |
$0.600 |
$0.600 |
fallen by
0%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$291 |
Weekly Estimated NTA as at 30 May 2025
|
2 Jun 2025 9:13AM |
$1.090 |
$0.920 |
fallen by
15.60%
|
|
| Opthea Limited (OPT) ORDINARY FULLY PAID |
Health Care |
$821 |
Final Director's Interest Notice Dr Susan Orr
|
2 Jun 2025 9:13AM |
$0.600 |
$0.600 |
fallen by
0%
|
|
| Opthea Limited (OPT) ORDINARY FULLY PAID |
Health Care |
$821 |
Final Director's Interest Notice Dr Julia Haller
|
2 Jun 2025 9:13AM |
$0.600 |
$0.600 |
fallen by
0%
|
|